Siah-1 is the mammalian homolog of Drosophila seven in absentia (sina) and has been identified as a p53-inducible gene. Siah-1 can induce cell cycle arrests, tumor suppression, and apoptosis through a novel b-catenin degradation pathway. To determine whether genetic alterations of Siah-1 gene are involved in the development and/or progression of gastric cancer, we searched for mutation of the Siah-1 gene in 95 gastric cancers by single-strand conformational polymorphism and sequencing. The effect of Siah-1 on b-catenin degradation was further examined in wild-and mutant-type Siah-1-transfected HEK 293T cells. We found two missense mutations of the Siah-1 gene. The cases with Siah-1 mutation showed nuclear translocation and cytoplasmic staining of b-catenin. Interestingly, two mutants of Siah-1 stabilized cytoplasmic levels of b-catenin, even after treatment of adriamycin. Furthermore, both mutants failed to suppress cyclin D1 expression and to induce apoptosis. These data suggest that inactivating mutations of the Siah-1 may contribute to the development of gastric cancer through b-catenin stabilization and apoptosis block.
Introduction
Gastric cancer occurs with a high incidence in Asia and is one of the leading causes of cancer deaths worldwide. In Korea, it accounts for an estimated 20.9% of all malignancies, with 24.4% in the male population and 16.3% in the female population (Suh et al., 2000) . However, little is known about the molecular genetic event in the development and progression of gastric cancer.
b-Catenin is a multifunctional protein that plays an important role in the transduction of Wnt signals and in the intercellular adhesion by linking the cytoplasmic domain of cadherin (Peifer and Polakis, 2000) . In general, the cytoplasmic level of b-catenin is kept low through interaction with a protein complex comprised of adenomatous polyposis coli (APC), Axin, protein phosphatase 2A, and glycogene synthase kinase 3b (GSK3b). It is believed that this complex phosphorylates the b-catenin, thereby inducing ubiquitinationdependent proteolysis of b-catenin. Therefore, alterations of these genes cause accumulation of cytoplasmic b-catenin and nuclear translocation of b-catenin. After its translocation into the nucleus, b-catenin binds to members of the Tcf/Lef family thereby activating target genes, such as cyclin D1 and myc. In cancer cells, only one of these genes is mutated in a given tumor sample reflecting their role in a common pathway (Lustig and Behrens, 2003) . For instance, colon tumors with mutations in APC have a wild-type b-catenin gene, and conversely, tumors with mutations in b-catenin are wild type for APC. In particular, most of the b-catenin mutations are activating mutations, mainly occurring at one of the four phosphorylation sites in exon 3 (Park et al., 1999; Polakis, 2001) .
Gastric cancer showed frequent genetic alterations of the APC gene, and the risk for gastric cancer in familial adenomatous polyposis patients is 10 times higher than that in the general population (Sivak and Jagelman, 1984; Nakatsuru et al., 1992) . The genetic alterations of exon 3 of the b-catenin gene, especially in GSK3b consensus sequence, have already been described. These findings raise the possibility that genetic analysis of genes for b-catenin degradation may be associated with the development of gastric cancer.
Siah is a human homolog of the Drosophila seven in absentia (sina), required for formations of the R7 photoreceptor cells during eye development (Carthew and Rubin, 1990) . The striking degree and sequence homology was observed between Drosophila and murine and two highly conserved human and murine homologs (Siah-1 and Siah-2) have been described (Della et al., 1993; Hu et al., 1997) . Siah-1 gene product has a RING finger domain that displays 76% aminoacid identity with sina protein and interacts with ubiquitin conjugating enzyme (E2) and promotes degradation of various target proteins via the ubiquitin-proteasome pathway (Hu and Fearon, 1999) . Interestingly, Siah-1 expression is induced by tumor suppressor p53 in mammals. Similar to p53, overexpression of Siah-1 inhibits cell proliferations, promotes apoptosis, and suppresses tumor formations . Taken together, all of these observations suggest that Siah-1 may be one of the tumor suppressor genes, which participate in the APCmediated downregulation of cytoplasmic b-catenin.
To investigate whether genetic alteration of the Siah-1 gene could be associated with the development or progression of gastric cancer, we performed mutational and functional analysis of Siah-1 in a series of 95 gastric cancers in Korea.
Results

Mutation of the Siah-1 gene
We analysed Siah-1 expression in 20 normal mucosal and cancer tissues, and nine gastric cancer cell lines at mRNA level. All of them expressed Siah-1 transcript (data not shown).
To investigate whether Siah-1 is involved in the gastric carcinogenesis, we searched for potential mutations in the entire coding region of the Siah-1 gene in 95 methacarn-fixed paraffin-embedded gastric cancer tissues by PCR-SSCP (single-strand conformation polymorphism) and sequencing analysis. Direct sequencing of the aberrantly migrating band on SSCP gel led to the identification of mutation in two (2.1%) of the gastric cancers examined. The mutations were missense mutations and identified in the exon 2 of the Siah-1 gene: a C to T transition at nucleotide 92 (Ser to Phe) in case No. 109 and an A to C transition at nucleotide 622 (Ile to Leu) in case No. 36 (Figure 1 ). The mutations are present in tumor cells, suggesting somatic mutation. Interestingly, SSCP gel of case No. 36 showed only aberrantly migrating mutant bands without wild-type bands, indicating homozygous mutation or mutation of one allele and loss of remaining allele (Figure 1 ). The cases with mutation are of advanced gastric cancer with surrounding lymph node metastasis. In an additional mutational study to exclude the presence of other mutations in b-catenin, APC, Axin, and b-TRCP genes in these two cases, no mutation was detected.
We repeated the experiments three times, including tissue microdissection, PCR, SSCP, and sequencing analysis to ensure the specificity of the results, and found that the data were consistent (data not shown).
Immunohistochemistry of b-catenin
To identify nuclear translocation of b-catenin protein in the cases with the Siah-1 mutation, we performed immunohistochemical analysis on formalin-fixed, paraffin-embedded tissue sections. Whereas b-catenin expression was observed mainly at the cell membrane in the normal gastric mucosa (Figure 2a) , the cancer cells demonstrated abnormal nuclear and cytoplasmic staining of b-catenin (Figure 2b ).
Loss of b-catenin degradation activity by the Siah-1 mutants
Since the Siah-1 reduced levels of endogenous b-catenin protein, we asked whether the mutants detected in this study could be involved in the b-catenin degradation pathway. After transient transfection in HEK 293T cell, expression of both wild-and mutant-type Siah-1 was confirmed by Western blot analysis using a monoclonal mouse anti-FLAG antibody. As shown in Figure 3a , the wild and mutant Siah-1 can be readily detected in all the cells. Expectedly, overexpression of Siah-1 wild type markedly reduced cytoplasmic b-catenin protein level and both mutants showed large ablation of the effects of Siah-1, thus maintaining cytoplasmic and nuclear b-catenin level ( Figure 3b ). The action of Siah-1 was specific, in that the level of IkB was not affected (Figure 3b ).
p53-dependent b-catenin degradation of the Siah-1
To investigate whether Siah-1-mediated downregulation of b-catenin was linked to p53, we cotransfected the (Figure 3c ). In addition, treatment of adriamycin also reduced b-catenin in wild-type Siah-1-transfected HEK 293T cells. However, overexpression of both mutant Siah-1s detected in this study had no effect on downregulation of b-catenin in HEK 293T cells (Figure 3d ). Furthermore, there was also no difference of cytoplasmic b-catenin level in wild-and mutant-Siah-1-transfected Hep3B p53-null cell line ( Figure 3e ).
Cyclin D1 expression by Siah-1 mutants
To determine whether the Siah-1 mutants could affect the target gene transcription, we analysed the level of cyclin D1 after the transient transfection of wild and mutant Siah-1. Expectedly, the level of cyclin D1 expression was lower in HEK 293T cells transfected with wild-type Siah-1 than those in cells transfected with mutants of Siah-1 and vector only. The expression of cyclin D1 in both mutants was 2.25-and 3.5-fold of that in wild-type Siah-1-transfected cells, suggesting that both mutants fail to suppress cyclin D1 expression (Figure 4 ).
Measurement of apoptosis
Cell death was assayed by staining of cells with FITClabeled Annexin V. Annexin V-positive cells (M2) were considered as apoptotic cells. Increased percentage of apoptotic cells were observed in wild-type Siah-1-transfected cells, whereas both mutant Siah-1s failed to induce apoptosis, like the vector only ( Figure 5 ). We repeated the experiment two times, and found that the data were consistent. Discussion b-Catenin is a multifunctional protein that plays an essential role in the transductions of Wnt signals. It may be regarded as existing in three different subcellular forms: membrane bound, cytosolic, and nuclear. Of these, cytosolic b-catenin may be subsequently degraded or translocated into the nucleus. Cytosolic b-catenin is eliminated by APC-dependent proteasomal degradation pathways regulated by GSK3b or p53-inducible Siah-1. Phosphorylation of serine and threonine residues on bcatenin is a crucial step required to target the protein for ubiquitination and proteosomal degradation. Conditional degradation of b-catenin represents a central event in Wnt signaling pathways controlling cell fate and proliferation (Lustig and Behrens, 2003) . Dysregulation of b-catenin turnover caused by alterations of Wnt signaling pathway-related genes is implicated in cancers (Kinzler and Vogelstein, 1996) . Interestingly, only one of these genes is mutated in a given tumor sample reflecting their role in a common pathway (Lustig and Behrens, 2003) .
Recently, Matsuzawa and Reed (2001) elucidated a network of protein interactions, in which Siah-1, SIP, SKP1, and Ebi collaborate in a pathway controlling b-catenin levels, affecting the activity of b-catenindependent Tcf/Lef transcription factors. This pathway is inducible by p53, revealing a link between genotoxic injury and b-catenin degradation. Interestingly, degradation of b-catenin by Siah-1 was independent of GSK3b-mediated phosphorylation and did not require the F-box protein b-TRCP. In the present study, we identified two somatic missense mutations of Siah-1 gene in gastric cancer (Figure 1 ). The cases with Siah-1 mutation demonstrated strong nuclear and moderate cytoplasmic staining of b-catenin in cancer cells (Figures  2 and 3 ). In addition, the mutant Siah-1s showed no effect on downregulation of cytoplasmic b-catenin in HEK 293T cells (Figure 3b ). To date, it has been reported that the N-terminal RING domain (aminoacid residue 39-76) of Siah-1 is required for its proteolysis function, while the C-terminal sequences of Siah-1 may regulate its oligomerization and binding to target proteins (Hu and Fearon, 1999) . Although the mutations of Siah-1 gene were detected in out of RING domain in this study, these results suggest that genetic alterations of the Siah-1 gene may inhibit degradation of cytoplasmic b-catenin and that inactivation of Siah-1 protein may contribute to the development and/or progression of a subset of gastric cancer.
After its translocation into the nucleus, b-catenin binds to members of the Tcf/Lef family, thereby activating target genes. Since Tcf/Lef factors cannot activate transcription on their own, b-catenin has been shown to provide transactivation domain (Clevers and van de Wetering, 1997; Hsu et al., 1998) . The identified target genes include c-myc and cyclin D1, an activator of cyclin-dependent kinases (Tetsu and McCormick, 1998; Shtutman et al., 2002) . Therefore, we explored the effects of mutant Siah-1s on cyclin D1 expression.
Interestingly, expression of cyclin D1 was suppressed in wild-type Siah-1-transfected cells, whereas mutant Siah-1s failed to suppress cyclin D1 expression (Figure 4) . We conclude, therefore, that inactivating mutations of Siah-1 may activate the transcription of cyclin D1 through the inhibition of the b-catenin degradation pathway and induction of nuclear translocation of b-catenin.
Recently, Siah-1 had been reported as a direct transcriptional target of p53 and regulator of cell cycle arrest and apoptosis in mammalian cells Matsuzawa et al., 1998; Roperch et al., 1999; Fiucci et al., 2004) . Human Siah-1 functions as a component of an E3 ubiquitin ligase complex including Siah-interacting protein, Skp1, and the F-box protein Ebi, which is proposed to target b-catenin for ubiquitinmediated degradation in response to activation of p53 (Liu et al., 2001; Matsuzawa and Reed, 2001; Polakis, 2001) . In the present study, mutant p53 completely inhibited wild-type Siah-1 effect on b-catenin degradation. In addition, although treatment of adriamycin markedly reduced b-catenin in HEK 293T cells transfected with wild-type Siah-1, adriamycin did not affect cytoplasmic b-catenin level not only in Hep3B p53-null cell line but also in HEK 293T cells with mutant Siah-1 (Figure 3c and d) . Taken together, these data suggest that p53 may activate the Siah-1-dependent b-catenin degradation pathway, and that the loss of function of either p53 or Siah-1 may induce accumulation of cytoplamic b-catenin and nuclear translocation of b-catenin.
Siah-1 had been reported as a regulator of apoptosis in mammalian cells (Roperch et al., 1999) . Thus, we examined the effect of Siah-1 on apoptosis with Annexin V staining and flow cytometry. While HEK 293T cells transfected with wild-type Siah-1 were sensitive to apoptosis, both mutant-transfected cells were resistant to apoptosis (Figure 5 ), suggesting that mutant Siah-1 may not be able to induce apoptosis.
Since two mutants of the Siah-1 gene detected in gastric cancer revealed impairment of the b-catenin degradation pathway, increase of cyclin D1 expression, and inhibition of apoptosis, we concluded that mutations of the Siah-1 gene may play an important role in the development and/or progression in a subset of gastric cancer through b-catenin stabilization and apoptosis block. Additional studies of large patient populations are needed to verify these initial observations and will certainly broaden our understanding of the pathogenesis of gastric cancer.
Materials and methods
Tissue samples
A total of 95 methacarn-fixed gastric cancer specimens were obtained from the College of Medicine, The Catholic University of Korea in Seoul, Korea. Informed consent was obtained from every patient. No patient had a family history. Nine gastric cancer cell lines (SNU1, SNU16, SNU216, SNU484, SNU620, SNU719, MKN28, MKN74, AGS) were also included in this study. 
Microdissection and DNA extraction
Tumor cells were selectively procured from hematoxylin & eosin-stained slides using a laser microdissection device (ION LMD, Biokhan Co., Seoul, Korea). We also obtained inflammatory or surrounding normal mucosal cells for the corresponding normal DNAs from the same slides in all cases. DNA extraction was performed by a modified single-step DNA extraction method, as described previously (Lee et al., 1998) .
RT-PCR
To analyse expression of Siah-1 in normal gastric mucosa and cancer tissue, and gastric cancer cell lines, first-strand cDNA was generated using the RNeasy and Oligotex mRNA mini kits (Qiagen, Hilden, Germany) and Superscript II Reverse Transcriptase (Invitrogen, Karlsruhe, Germany). In total, 5 ml of first-strand cDNA preparations were used in PCR reactions with 30 cycles. Primer sequences are 5 0 -CATTCGCAACTT GGCTATGGAGA-3 0 for sense and 5 0 -GATTGCGAAGA ACTGCTGGTGAC-3 0 for antisense.
Mutational analysis
Genomic DNAs from cancer cells and the corresponding noncancerous gastric mucosal tissue were amplified with five sets of primers covering the entire coding region (exons 1 and 2) of the Siah-1 gene (Table 1) . Numbering of DNA of the Siah-1 was carried out in respect to the ATG start codon according to the genomic sequence of Genbank Accession no. NM003031. Each PCR reaction was performed under standard conditions in a 10 ml reaction mixture containing 20 ng of template DNA, 0.5 mM of each primer, 0.2 mM of each deoxynucleotide triphosphate, 1.5 mM MgCl 2 , 0.4 U of Taq polymerase, 0.5 mCi of [ 32 P]dCTP (Amersham, Buckinghamshire, UK), and 1 ml of 10X buffer. The reaction mixture was denatured for 12 min at 941C and incubated for 35 cycles (denaturing for 40 s at 941C, annealing for 40 s at 52-571C, and extending for 40 s at 721C). The final extension was continued for 5 min at 721C. After amplification, PCR products were denatured for 5 min at 951C at a 1 : 1 dilution of sample buffer containing 98% formamide/5 mmol/l NaOH and were loaded onto a SSCP gel (Mutation Detection Enhancement, FMC BioProducts, Rockland, ME, USA) with 10% glycerol. After electrophoresis, the gels were transferred to 3 MM Whatman paper and dried, and autoradiography was performed with Kodak X-OMAT film (Eastman Kodak, Rochester, NY, USA). For the detection of mutations, DNAs showing mobility shifts were cut out from the dried gel, and reamplified for 30 cycles using the same primer set. Sequencing of the PCR products was carried out using the cyclic sequencing kit (Perkin-Elmer, Foster City, CA, USA) according to the manufacturer's recommendation.
Immunohistochemistry for b-catenin
To detect the localization of b-catenin in the case with Siah-1 mutation, the mouse monoclonal anti-b-catenin antibody (bcatenin, Transduction Laboratories, Lexington, KY, USA) was used. Antigen retrieval was performed by microwave heating in a citrate buffer (pH 6.0). Other procedures were performed as previously described . Reaction products were developed with diaminobenzidine (Sigma, St Louis, MO, USA) and counterstained with hematoxylin. Immunohistochemistry was also carried out in 10 gastric cancer cases with wild type of b-catenin, Siah-1, and p53 genes. As a negative control, we used nonimmune mouse serum instead of the b-catenin antibody.
Site-directed mutagenesis
For functional analysis of Siah-1 mutants detected in gastric cancer, site-directed mutagenesis was performed using a Quick Change Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA), according to the manufacturer's instructions. To change a base, a plasmid containing the Siah-1 gene in pcDNA3-FLAG was used as a template. The nucleotide sequences of the mutagenized plasmids were confirmed by sequencing (data not shown).
Cell culture and transfection
Since there is no exact information of the genetic alterations of Wnt signaling pathway-related genes in established gastric cancer cell lines, human embryonic kidney 293T cells were cultured at 371C in 5% CO 2 in Dulbeco's modified Eagle's medium with 10% heat-inactivated fetal bovine serum. To find out the relationship between p53 and Siah-1, the mutant form (R248W) of p53 gene and hepatocellular carcinoma Hep3B p53-null cell line was also used. Cells in log phase were transfected in 60 mm-diameter dishes with expression plasmids (5 mg total DNA) using lipofectamine Plus transfection reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer's recommendations.
b-Catenin measurement
Cells were harvested 48 h later and lysed in ice-cold Nonidet P-40 lysis buffer (10 mM HEPES (pH 7.4), 142.5 mM KCl, 0.2% Nonidet P-40, 5 mM EGTA) supplemented with 1 mM dithiothreitol, 12.5 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1mM phenylmethylsulfonyl fluoride, and 1 Â protease inhibitor mix (Roche Molecular Biochemicals, Mannheim, Germany). To isolate endogenous cytosolic b-catenin, cells were disrupted in ice-cold hypotonic buffer containing 10 mM Tris-HCl (pH 7.5), 10 mM KCL, 0.1 mM EDTA, and protease inhibitors cocktail (Boehringer Mannheim, Mannheim, Germany) by passaging 15 times through a 26-gauge needle. Cell extracts were clarified by centrifugation at 16 000 g for 30 min at 41C. To isolate nuclear b-catenin, cells were incubated on ice for 10 min in 10 mM HEPES-KOH buffer (pH 7.9) containing 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 5 mM sodium fluoride, 5 mM sodium orthovanadate, and 0.5 mM p-ABSF. Cells were disrupted with a Dounce homogenizer. After centrifugation, nuclei were resuspended in 20 mM HEPES-KOH buffer (pH 7.9) containing 400 mM NaCl, 1.5 mM MgCl 2 , 25% glycerol, 0.1 mM EDTA, 1 mM DTT, 5 mM sodium fluoride, 5 mM sodium orthovanadate, and 0.5 mM p-ABSF and incubated at 41C for 60 min. The mixture was centrifuged at 16 000 g for 30 min at 41C, and the supernatant was recovered as nuclear extracts. The resulting supernatants (40 mg total protein) were separated by 8% SDS-PAGE and transferred to nitrocellulose membranes. The resulting blots were incubated with anti-b-catenin monoclonal antibody, followed by horseradish peroxidase-conjugated secondary antibodies and detected by an enhanced chemiluminescence method (Amersham Pharmacia Biotech, Buckinghamshire, UK).
Since activation of p53 by genotoxic reagents induces Siah expression and triggers Siah-mediated downregulation of bcatenin (Peifer and Polakis, 2000) , HEK 293T cells were treated with 1 mg/ml adriamycin, which activates endogenous p53, 8 h after transfection for 16 h. Additionally, we also examined cytoplasmic b-catenin level in Hep 3B p53-null cell lines after Siah-1 transfection.
Next, to investigate the effect of Siah-1 on cyclin D1 expression, total cell lysate (0.5 ml) was clarified by centrifugation at 16 000 g for 5 min, and were fractionated by SDS-PAGE and transferred to nitrocellulose membranes. Proteins were detected with anti-cyclin D1 monoclonal antibody (Santa Cruz-Biotechnology, Santa Cruz, CA, USA).
Measurement of apoptosis by using Annexin V staining
Annexin V binds to those cells that express phosphatidylserine on the cell membrane, and propidium iodide (PI) stains the cellular DNA of cells with a compromised cell membrane. Annexin V-binding assay was performed according to the manufacturer's instruction. Transfected HEK293 cells were washed twice in cold PBS and resuspended in 100 ml binding buffer. In each case, 100 ml of the supernatant was mixed with 400 ml of blocking solution. After 5 ml (1 mg/ml) of Annexin V-FITC and 5 ml of PI (2 mg/ml) were added to the mixture and incubated in the dark for 15 min, cells were analysed on fluorescence-activated cell sorter (BD Biosciences, Pharmingen, CA, USA). Only fluorescent-positive cells without PI staining were regarded as apoptotic cells.
